Hill Research's Contribution to Biomedical AI Explored at SAPA-CT Symposium

At the “Inaugural AI Symposium in Biomedicine” hosted by SAPA-CT at Yale University, Hill Research CEO Louise Liu, PhD, MBA joined a distinguished panel of speakers including Hanrui (Raye) Zhang from the FDA, Yingchao "YZ" Zhang, Ph.D. from opAIda, Inc., and others from leading AI and healthcare organizations. The event brought together experts to explore how artificial intelligence is reshaping biomedicine across policy, research, and commercialization.

In the session titled “Empowered by AI – People & Business in the AI Era," Louise shared practical insights into how AI is transforming clinical trials, from operational strategy and workforce development to innovation in trial execution. Hill Research’s presence underscored its role in not just following AI trends but actively shaping the future of biomedical research through responsible and forward-thinking applications of AI.

Hill Research's presence at the symposium highlighted its operational capabilities and the current applications of AI in accelerating and refining clinical research processes. The company’s engagement in such forums contributes to the ongoing dialogue about the responsible and effective integration of AI technologies across the biomedical sector.